Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for differences in gene expression between the cell lines derived from different tumour samples, and to investigate if these differences can be used to cluster the cell lines into distinct groups. Dividing the cell lines into classes can help to improve diagnosis and the development of screens for new drug candidates. The micro-array data is first subjected to quality control analysis and then subsequently normalised using three alternate methods to reduce the chances of differences being artefacts resulting from the normalisation process. The final clustering into sub-classes was carried out in a conservative manner such that sub-classes were consi...
Abstract Background NCI60 cell lines are derived from cancers of 9 tissue origins and have been inva...
Objective Non-small-cell lung cancer (NSCLC) accounts for >85% of lung cancers, and its incidence is...
Background Lung cancer remains the world-wide leading cause of cancer morbidity and mortality as a ...
Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for dif...
<div><p>Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look...
Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for dif...
AbstractObjectiveThis study hypothesized that non–small cell lung carcinoma cells from primary tumor...
Recent studies have suggested that information from gene expression profiles could be used to develo...
Abstract Methods We examined gene expression profiles of tumor cells from 29 untreated patients with...
Among non-small cell lung cancer (NSCLC), adenocarcinoma (AC), and squamous cell carcinoma (SCC) are...
We performed a series of bioinformatics analysis on a set of important gene expression data with 76 ...
Gene expression profiling has been used to characterize prognosis in various cancers. Earlier studie...
The present work analyzed the gene pattern profiles in 6 squamous non-small cell lung cancers (NSCLC...
Cancer cell lines are widely used in basic research to study cancer development, growth, invasion, o...
Microarrays have been used for more than two decades in preclinical research. The tumor transcriptio...
Abstract Background NCI60 cell lines are derived from cancers of 9 tissue origins and have been inva...
Objective Non-small-cell lung cancer (NSCLC) accounts for >85% of lung cancers, and its incidence is...
Background Lung cancer remains the world-wide leading cause of cancer morbidity and mortality as a ...
Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for dif...
<div><p>Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look...
Microarray data from cell lines of Non-Small Cell Lung Carcinoma (NSCLC) can be used to look for dif...
AbstractObjectiveThis study hypothesized that non–small cell lung carcinoma cells from primary tumor...
Recent studies have suggested that information from gene expression profiles could be used to develo...
Abstract Methods We examined gene expression profiles of tumor cells from 29 untreated patients with...
Among non-small cell lung cancer (NSCLC), adenocarcinoma (AC), and squamous cell carcinoma (SCC) are...
We performed a series of bioinformatics analysis on a set of important gene expression data with 76 ...
Gene expression profiling has been used to characterize prognosis in various cancers. Earlier studie...
The present work analyzed the gene pattern profiles in 6 squamous non-small cell lung cancers (NSCLC...
Cancer cell lines are widely used in basic research to study cancer development, growth, invasion, o...
Microarrays have been used for more than two decades in preclinical research. The tumor transcriptio...
Abstract Background NCI60 cell lines are derived from cancers of 9 tissue origins and have been inva...
Objective Non-small-cell lung cancer (NSCLC) accounts for >85% of lung cancers, and its incidence is...
Background Lung cancer remains the world-wide leading cause of cancer morbidity and mortality as a ...